spacer
home > pmps > spring 2007 > bespoke code reading – a prescription for less confusion,
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bespoke Code Reading – A Prescription for Less Confusion,

Richard Laight and Charlie Plain-Jones at Absolute Vision address the role of bespoke packaging and labelling in the pharmaceutical industry

The need for bespoke packaging and labelling in the pharmaceutical market place is becoming ever greater. This is due to a number of factors, including an increase in legislation. This legislation not only requires manufacturers to ensure full and detailed product labelling, which, in itself, must provide information for the end user, for example date of production and expiry, but also information capable of providing a traceable history for that particular batch. The second factor that is having an impact on packaging and labelling in the pharmaceutical industry is the change in production and distribution processes in response to evolving so called ‘borderless’ and global markets.

IMPACT ON THE INDUSTRY

A high percentage of medicines returned to manufacturers by the distribution chain are returned – not because they are faulty but because they have been packaged incorrectly, possibly in the wrong language or with the wrong product name for that specific market or with a basic error, such as an incorrect dosage level. With the majority of pharmaceutical items there are three distinct parts to the packaging:

  • The bottle on the label or on the foil surrounding the tablet or pill
  • The printed insert giving details of dosage, side effects and so on
  • The final external protective carton or box that is displayed on the chemist’s shelf

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Richard Laight is co-founder and Business Development Manager of Absolute Vision Ltd, a specialist developer of data matrix and optical character reading solutions. Richard has over 22 years’ experience of working in the computer industry, primarily in a software development role. His career began in the public sector, working on the development of educational software under a crown copyright for national schools and colleges. Later, Richard moved into the corporate sector and was involved in the deployment of large networks into blue-chip companies and qualified as a Novell and Microsoft Certified Network Engineer (CNE). Richard set up Absolute Vision Ltd with colleague Peter Greenrod to develop their mutual interests in machine vision. The business was incorporated in February 2001 and began trading in June 2001.

Charlie Plain-Jones joined Absolute Vision in June 2003 to lead the company’s expansion programme in quality-driven industries; such as aerospace, automotive, electronics and healthcare. Charlie has spent 20 years in sales and business development for mainly US-based corporations, migrating leading-edge technologies into Europe. Charlie is experienced in a number of automated manufacturing processes, and, most recently, he has worked in the European business development of advanced Data Matrix 2D symbology reading systems. Charlie has taken an active role in defining relevant standards within these industries. Working in Europe and the near-East, Charlie has been involved in large-scale implementation programmes in several industries. Charlie gained an honours degree in Electronic Engineering at the University College of North Wales (UCNW).

spacer
Richard Laight
spacer
spacer
spacer
Charlie Plain-Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing the new Rapidox 7100

When dealing with volatile applications such as those within chemical and combustion processes, you need a high specification instrument you can trust; the Rapidox 7100 Multigas Analyser is that instrument
More info >>

White Papers

Planning the Execution of a Viral Clearance Study

Eurofins BioPharma Product Testing

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or commercial product approval for all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove or inactivate viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise to perform. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house. When multiple parties are involved in this process, clear communication and a comprehensive understanding of the approach and timeline is critical.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement